BSH 55th Annual Scientific Meeting


20-22 April 2015 Edinburgh
N. Poster
Poster title
Applicant name
  47-P A survey of regional anaesthetic practice in immune and gestational thrombocytopenia in pregnancy Marwa Salman Received Received
  49-P Audit of the use of chest X-rays in the management of adult neutropenic sepsis at Kings College Hospital, London CY Zhu Received Received
  51-P Anticoagulation in patients undergoing cardioversion at Hampshire Hospitals NHS Foundation Trust Sufyan Benamer Received Received
  52-P A study of the implementation of romiplostim & eltrombopag in the NHS in England Lisa Cooper Received Received
  53-P Evaluation of the body fluid mode on the XE-5000 for counting leukocytes in bronchoalveolar lavage fluid Lucie Gruchalova Received Received
  55-P The impact of formal chemotherapy training on haematology registrars Joanna Collins Received Received
  56-P Formalising palliative care education augments clinical skills in haematology trainees Rosanna Ghinai Received Received
  58-P Idiopathic systemic capillary leak syndrome treated successfully with maintenance intravenous immunoglobulin Andrew King Received Received
  59-P Management of the Choose and Book system for polycythaemia/thrombocytosis by the MPN specialist nurse Louise Wallis Received Received
  61-P The development and review of performance assessment scoring in blood films for parasites external quality assessment Paul McTaggart Received Received
  62-P Second line treatment for immune thrombocytopenia (ITP): A review of patients with ITP in Basildon Hospital Katie White Received Received
  72-P New conclusions in scintigraphy results of sickle cell disease bone involvements Hasan Al-Jafar Received Received
  76-P Annual British Society for Haematology confidential survey of bone marrow examination associated adverse events 2013 Vinod Devalia Received Received
  81-P The use of thrombopoeitin (TPO) as a Biomarker in Immune Thrombocytopenia (ITP) George Adams Received Received
  82-P The effects of Triton-X on haematological assays when used as an inactivator for Ebola virus Alexander Gatt Received Received
  83-P A case report may lead to addendum to BSH treatment guideline of acquired VWD Hassan Al-Jafar Received Received
  87-P Recurrence of VTE over four years: Local outcome data to determine and compare location of VTE events for hospital or community acquired VTE Huw Rowswell Received Received
  88-P Direct oral anti-coagulants for prevention of stroke and systemic embolism in non-valvular atrial fibrillation Barts Health experience across two sites Pallavi Kalkur Received Received
  90-P A double-centre retrospective study into rates of postpartum haemorrhage in women on low molecular weight heparin Rachel Browne Received Received
  91-P Acute nurse-led VTE service reduces admission and facilitates NOAC use for VTE Marianna Koperdanova Received Received
  93-P Audit of the effect of the introduction of a guideline for the management of superficial vein thrombosis to a nurse-led DVT clinic Charlotte Grimley Received Received
  94-P Evaluation of pathology quality assurance review recommendations: Data from a UK NEQAS for Blood Coagulation (UK NEQAS BC) questionnaire Shelene Munroe-Peart Received Received
  99-P Review of factor XI deficiency: Bleeding phenotype and clnical considerations Philip George Received Received
  103-P Cancer-associated VTE occurring over one year in a small district general hospital Emma Harris Received Received
  104-P Patients with suspected TTP should be acutely managed in a critical care setting Jennifer Burgess Received Received
  108-P Thrombopoietin-receptor agonists in immune thrombocytopaenic purpura: Our experience at East Kent Hospitals University NHS Foundation Trust Kate Fletcher Received Received
  120-P Burden of venothromboembolism and thromboprophylaxis at East Kent Hospitals NHS Foundation Trust in patients with myeloma treated with immunomodulatory drugs (IMid) containing regimens between 2009 and 2014: A retrospective study Catherine Roughley Received Received
  121-P Prospective audit of rivaroxaban as thromboprophylaxis and treatment during myeloma therapy with immunomodulatory drugs (IMiDs) at East Kent Hospitals NHS Foundation Trust Catherine Roughley Received Received
  123-P MGUS Tracker an alternative way of monitoring MGUS outside the haematology clinic Heather Eve Received Received
  127-P An audit of compliance with the NICE guideline for the use of lenalidomide therapy in patients with myeloma ANANDIKA LIYANAGE Received Received
  128-P Significant gender differences in the number and distribution of T cells in patients with mantle cell lymphoma Nimish Shah Received Received
  132-P Rare, fulminant presentations of anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma a case series Xiao-Yin Zhang Received Received
  134-P Outcomes from a single centre for patients with multiply relapsed myeloma treated with bendamustine containing regimens Noel Ryman Received Received
  139-P Audit of central nervous system (CNS) prophylaxis in patient with diffuse large B-cell lymphoma (DLBCL) Abdul Baseer Qadri Received Received
  142-P Life-threatening bowel perforation while on thalidomide-based triplet regimen for multiple myeloma: A retrospective case series Priya Sriskandarajah Received Received
  148-P Off trial use of brentuximab vedotin in Hodgkin lymphoma a regional experience Joseph Browning Received Received
  156-P Retrospective observational study of patients with relapsed/refractory myeloma treated with pomalidomide - the UK Experience Priya Sriskandarajah Received Received
  165-P Real world efficacy of pomalidomide for relapsed myeloma - a multicentre restrospective study Matthew Wells Received Received
  181-P Optimisation of RNA extraction and RT-qPCR for the quantification of AID in archived FFPE biopsy samples: only two sections of 4 micrometre tissue are required Omar Alishlash Received Received
  187-P Efficacy of azacitidine in the treatment of acute myeloid leukaemia (blasts 30) in comparison to MDS John Gaffney Received Received
  188-P Investigating differences in serum and plasma values in galactomannan testing, signal loss and sources of false positivity Naeem Desai Received Received
  191-P Frequency and management of breakthrough fungal infections in patients with acute myeloid leukaemia (AML) and acute lymphocytic leukaemia (ALL) on antifungal prophylaxis Claire Burney Received Received
  193-P Single centre experience in the use of pegylated interferon alpha for myeloproliferative neoplasms Meghna Ruparelia Received Received
  199-P Convenient care for patients: A real world evaluation to describe the NHS impact of administering velcade R (bortezomib) in a home setting for patients with multiple myeloma Samantha Oliver Received Received
  201-P Alternate day lenalidomide as a well-tolerated and cost-effective treatment in multiple myeloma Yeong Jer Lim Received Received
  204-P CALR mutations in myeloproliferative neoplasm related splanchnic vein thrombosis Mallika Sekhar Received Received
  206-P How well are patients with myeloproliferative neoplasms assessed for cardiovascular risk: An audit report Mallika Sekhar Received Received
  220-P Seroprevalence of undiagnosed transfusion transmissible infections (HIV, hepatitis B and C and syphilis) in donated blood in National Blood Banks, Khartoum, Sudan doaa yousif Received Received
  224-P The impact of maternal allo-antibodies on the clinical outcomes of foetuses/neonates at Barts Health NHS Trust Jessica Jardim Received Received
  226-P Incidence of Rh and Kell blood group antigens among blood donors in Qatar Ibrahim Mustafa Received Received
  227-P Consent to long-term multiple blood transfusions for patients admitted to the haematology ward: A complete audit cycle and quality improvement project Helen Perera Received Received
  230-P Successful renal transplantation in Jehovahs Witnesses shouldnt we apply our approach to blood refusers to all patients, to reduce risks associated with blood transfusions? Charlotte Phillips Received Received
  231-P Contribution of the British Bone Marrow Registry (BBMR) to the UK transplant activity in 2007 and investigation of final donors in this year Yousif Aawsaj Received Received
  232-P The use and outcomes of prothrombin complex concentrate in a district general hospital julie blundell Received Received
  238-P High recruitment into interventional clinical trials is possible in the setting of a district general trust (DGT): Results of a short prospective audit LAVINIA DAVEY Received Received
  255-P Haemoglobinopathy screening pathways and attitudes to opportunistic screening for haemoglobinopathies Meghna Ruparelia Received Received
  257-P Safety and efficacy of elective automated red cell exchange transfusion programmes for patients with sickle cell disease Paul Miller Received Received
Tel.: +34 91 736 2385
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name


BSH 55th Annual Scientific Meeting


20-22 April 2015 Edinburgh


Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 20/04/2015 TO 20/04/2016
Featured Poster
Vote poster
Poster Discussion
                   DOI: 10.3252/ 

Logo Draft
Logo Cert